Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 AUD | +4.35% | +14.29% | +118.18% |
04-09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
02-28 | Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Anatara Lifesciences Ltd
Upcoming events on Anatara Lifesciences Ltd
Past events on Anatara Lifesciences Ltd
28/02/2024 00:52 | Q2 2024 Earnings Release |
23/01/2024 22:36 | December 2023 Sales and Revenue Release - Activities Report |
09/11/2023 23:30 | Annual General Meeting |
18/10/2023 | Irritable Bowel Syndrome Stage 1 Clinical Trial Results Call |
24/08/2023 00:33 | Q4 2023 Earnings Release |
18/07/2023 23:20 | June 2023 Sales and Revenue Release - Activities Report |
19/04/2023 23:07 | March 2023 Sales and Revenue Release - Activities Report |
23/02/2023 22:08 | Interim 2023 Earnings Release |
11/01/2023 21:21 | December 2022 Sales and Revenue Release - Activities Report |
11/12/2022 | Shareholders Meeting |
10/11/2022 | Annual General Meeting |
28/08/2022 | FY 2022 Earnings Release |
01/08/2022 00:02 | June 2022 Sales and Revenue Release - Activities Report |
28/04/2022 | March 2022 Sales and Revenue Release - Activities Report |
23/02/2022 22:59 | Interim 2022 Earnings Release |
26/01/2022 | December 2021 Sales and Revenue Release - Activities Report |
08/12/2021 | Gastro Congress |
16/11/2021 | Microbiome Connect Conference |
15/11/2021 | Annual General Meeting |
03/11/2021 | USA Microbiome R&D and Business Collaboration Forum |
Annual results
Fiscal Period | June | 2019 |
---|---|---|
Net sales Million AUD | Released Forecast Spread | 1,50 1,70 -11.51% |
EBITDA Million AUD | Released Forecast Spread | -2,99 -2,90 -3.04% |
EBIT Million AUD | Released Forecast Spread | -3,01 -3,10 2.88% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - |
Net income Million AUD | Released Forecast Spread | -2,87 -2,60 -10.32% |
EPS AUD | Released Forecast Spread | -0,06 -0,05 -12.38% |
Announcement Date | 26/08/19 |
Today 11:25 | ELI LILLY AND COMPANY: Q1 2024 Earnings Release |
30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
01/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
Past sector events for Anatara Lifesciences Ltd
- Stock Market
- Equities
- ANR Stock
- Calendar Anatara Lifesciences Ltd